A detailed history of Northwest Bank & Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Northwest Bank & Trust CO holds 55 shares of AZN stock, worth $3,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 55 -0.0%
Holding current value
$3,477
Previous $4.29 Million 0.12%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$69.91 - $75.81 $3,845 - $4,169
55 New
55 $3.94 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Northwest Bank & Trust CO Portfolio

Follow Northwest Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bank & Trust CO with notifications on news.